ADAM VOGEL to Carcinoma, Hepatocellular
This is a "connection" page, showing publications ADAM VOGEL has written about Carcinoma, Hepatocellular.
Connection Strength
0.578
-
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 10 01; 29(Suppl 4):iv238-iv255.
Score: 0.313
-
Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohort. ESMO Open. 2023 02; 8(1):100783.
Score: 0.106
-
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO. Ann Oncol. 2020 03; 31(3):334-351.
Score: 0.085
-
Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis. Aliment Pharmacol Ther. 2018 02; 47(4):516-525.
Score: 0.074